PTSD Trial, Recruiting NCT05485701 Sponsor: University of Oxford Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT05485701
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For Phases 1 and 2 of the study:

  • Women aged 18 to 45 who are currently pregnant (at any stage of pregnancy) and are willing and able to give informed consent.
  • Women aged 18 to 45 who have given birth within the past 1 to 12 months and are willing and able to give informed consent.
  • Women aged 18 to 45 who are not currently pregnant and have not given birth in the past 12 months, and are willing and able to give informed consent.

For Phase 3 of the study:

  • Women aged 18 to 45 who are in early pregnancy (before 20 weeks) at the time of joining, are not planning to move away during the study, are willing and able to give informed consent, and are willing to attend four planned visits.
  • Women aged 18 to 45 who are not currently pregnant and have not given birth in the last 12 months, are not planning to move away during the study, are willing and able to give informed consent, and are willing to attend four planned visits.

Who may not be able to join:

  • People with a severe and acute psychiatric illness that affects their ability to take part in the study.
  • People who are not willing or able to give informed consent.

The trial notes that having a current or past physical, psychological, or psychiatric condition does not automatically prevent participation, as long as the ability to take part and give informed consent is not affected (confirm with trial site).


Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gracia Fellmeth, DPhil, University of Oxford

Phone: 00441865289745

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2022
Est. completion
31 August 2025

Where this trial is recruiting

🇮🇳 India

Primary endpoints

Phase 1: Codes and themes relating to acceptability of screening for perinatal mental disorders; Phase 2: Psychometric properties of screening tools for common mental disorders; Phase 3: Point prevalence, period prevalence and incidence (with 95% confidence intervals) of common mental disorders among perinatal and non-perinatal women; Phase 3: Odds ratios (with 95% confidence intervals) for factors associated with common mental disorders among perinatal and non-perinatal women

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov